Mohammad Mobayed, MD

Hematology/oncology in Rochester Hills, MI

3950 S Rochester Rd, Suite 1400, Rochester Hills, MI 48307
NPI 1114134632 Accepts Medicare assignment Offers telehealth 22 years since graduation Public record — not managed by the clinician

About Dr. Mohammad Mobayed

Dr. Mohammad Mobayed is a physician specializing in hematology/oncology practicing in Rochester Hills, MI. Records list 2 practice addresses. Affiliated with Corewell Health Beaumont Grosse Pointe Hospital, Corewell Health Beaumont Troy Hospital, Corewell Health William Beaumont University Hospit and 2 more. Treated 437 Medicare patients in 2024.

SpecialtyHematology/oncologyOther hematology/oncology doctors in Rochester Hills
Also practicesInternal Medicine
CredentialsMD
GenderMale
NPI number1114134632National Provider Identifier (CMS NPPES), issued May 2007
MedicareEnrolled in Medicare; accepts Medicare assignment (the Medicare-approved amount as full payment)CMS Doctors and Clinicians
TelehealthOffers telehealth servicesCMS Doctors and Clinicians

Where Dr. Mohammad Mobayed practices

Addresses from CMS Doctors and Clinicians (Medicare enrollment). Call before visiting: a clinician may not see patients at every listed address.

Dr. Mohammad Mobayed's specialties and state licenses

Specialty (NPPES)License
Hematology & Oncology PrimaryMI 4301085805
Hematology & OncologyTX P6682

As reported by the clinician to the NPPES registry. Confirm a license and any disciplinary history with the state medical or licensing board.

Hospital affiliations of Dr. Mohammad Mobayed

  • Corewell Health Beaumont Grosse Pointe HospitalHospital · Grosse Pointe, MI
  • Corewell Health Beaumont Troy HospitalHospital · Troy, MI
  • Corewell Health William Beaumont University HospitHospital · Royal Oak, MI
  • Henry Ford Health Macomb HospitalHospital · Clinton Township, MI
  • Henry Ford Rochester HospitalHospital · Rochester, MI

CMS Facility Affiliation data: facilities where the clinician bills Medicare.

Dr. Mohammad Mobayed's Medicare patients and services (2024)

437Medicare patients
89,604services billed
76average patient age
60%women

Most frequent services

ServiceTimesAvg. Medicare allowed
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more846$118.21
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes653$110.44
Injection of drug or substance under skin or into muscle305$13.11
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's282$15.31
Administration of chemotherapy into vein, 1 hour or less266$117.91
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less253$25.77
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes239$160.92
Injection of additional new drug or substance into vein186$14.05

Common conditions among these patients

  • High cholesterol75%
  • High blood pressure75%
  • Arthritis52%
  • Ischemic heart disease42%
  • Diabetes38%
  • Chronic kidney disease35%

Medicare Part B fee-for-service claims only (CMS Medicare Physician & Other Practitioners, 2024). Patients with private insurance or Medicare Advantage are not counted; small counts are suppressed by CMS. This describes the patients, not the quality of care.

Dr. Mohammad Mobayed's Medicare quality score (MIPS 2024)

75/100final MIPS score

The Merit-based Incentive Payment System scores clinicians who bill Medicare. Reported as group. Source: CMS Care Compare, PY 2024 clinician public reporting.

Payments from drug and device companies to Dr. Mohammad Mobayed (2025)

$5,915.68 in 140 general payments reported in 2025.

TypePaymentsAmount
Food and beverage138$3,215.68
Consulting fees1$2,680
Education1$20

Paying companies: AstraZeneca Pharmaceuticals LP ($2,880.21), Janssen Biotech, Inc. ($288.57), Daiichi Sankyo Inc. ($255.25), Genentech USA, Inc. ($209.12), Boehringer Ingelheim Pharmaceuticals, Inc. ($146.93), E.R. Squibb & Sons, L.L.C. ($111.87).

Reported by companies under the federal Open Payments program (CMS, program year 2025). A payment, such as a meal at an educational event, does not mean wrongdoing; clinicians can dispute records with CMS.

Questions about Dr. Mohammad Mobayed

What kind of clinician is Dr. Mohammad Mobayed?

Dr. Mohammad Mobayed is listed as a physician specializing in hematology/oncology, also practicing internal medicine.

Where does Dr. Mohammad Mobayed practice?

The main practice address at 3950 S Rochester Rd, Suite 1400, Rochester Hills, MI 48307, and 1 other address in the records.

What is the office phone number for Dr. Mohammad Mobayed?

The listed office number is (248) 494-4444. Call to confirm availability and whether new patients are accepted.

What is the NPI number of Dr. Mohammad Mobayed?

The National Provider Identifier is 1114134632.

Does Dr. Mohammad Mobayed accept Medicare?

Yes. CMS lists this clinician as accepting Medicare assignment. Confirm your plan with the office.

Which hospitals is Dr. Mohammad Mobayed affiliated with?

Corewell Health Beaumont Grosse Pointe Hospital, Corewell Health Beaumont Troy Hospital, Corewell Health William Beaumont University Hospit, Henry Ford Health Macomb Hospital, Henry Ford Rochester Hospital.

Where this information comes from

CMS Doctors and CliniciansName, specialty, education, Medicare enrollment and practice addresses.Centers for Medicare & Medicaid Services, national downloadable file (2026)
NPPES NPI registryNPI, specialties (taxonomy) and state licenses.CMS National Plan and Provider Enumeration System; record updated 2023-05-26
Facility affiliationsHospitals and other facilities.CMS Doctors and Clinicians facility affiliation file; names from CMS Provider of Services
Medicare utilizationPatients, services and conditions.CMS Medicare Physician & Other Practitioners, 2024
MIPSQuality payment program scores.CMS clinician public reporting, PY 2024
Open PaymentsPayments from drug and device companies.CMS Open Payments, program year 2025

Information is public record and may lag behind changes. Clinicians update it through NPPES and Medicare PECOS. See something wrong? Tell us.

0 clinics selected Compare